Top Buy
| Security | Buy | Sell | Buy (1W) | Sell (1W) ▲ | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Glaukos Corp | 1 | 0 | 0 | 0 | €121.00 | - | - |
| Emergent Biosolutions Inc. | 9 | 2 | 2 | 0 | €6.69 | €7.44 | 11.304% |
| Eledon Pharmaceuticals Inc. | 6 | 0 | 0 | 0 | €2.48 | €12.21 | 392.375% |
| AstraZeneca plc | 2 | 0 | 0 | 0 | €155.70 | €165.00 | 5.973% |
| Molina Healthcare | 17 | 1 | 0 | 0 | €322.50 | €370.26 | 14.809% |
| Align Technology | 21 | 2 | 0 | 0 | €205.10 | €308.48 | 50.407% |
| Veracyte Inc. | 1 | 0 | 0 | 0 | €28.40 | - | - |
| Stratec SE | 3 | 0 | 0 | 0 | €43.85 | €0.000 | -100.000% |
| Knight Therapeutics | 1 | 0 | 0 | 0 | €3.66 | €10.00 | 173.224% |
| Staar Surgical Co. | 13 | 1 | 0 | 0 | €29.91 | €47.59 | 59.123% |
| Adverum Biotechnologies Inc. | 11 | 0 | 0 | 0 | €1.38 | €23.35 | 1591.667% |
| ProQR Therapeutics N.V. | 7 | 2 | 0 | 0 | €1.85 | €2.32 | 25.720% |
| R1 RCM Inc. | 23 | 0 | 0 | 0 | €12.60 | €17.21 | 36.608% |
| Biolife Solutions Inc | 1 | 0 | 0 | 0 | €23.20 | - | - |
| Pro-Dex Inc. | 11 | 0 | 1 | 0 | €20.60 | - | - |
| Axsome Therapeutics Inc | 1 | 0 | 0 | 0 | €81.14 | €100.00 | 23.244% |
| Purple Biotech Ltd. ADR | 7 | 0 | 0 | 0 | €0.38 | €9.21 | 2310.209% |
| Rhythm Pharmaceuticals | 15 | 0 | 0 | 0 | €44.80 | €46.51 | 3.806% |
| Motus GI Holdings Inc. | 1 | 0 | 0 | 0 | €0.43 | €2.37 | 452.929% |
| Nektar Therapeutics | 4 | 1 | 0 | 0 | €1.12 | €2.40 | 114.477% |
| Merck & Co. Inc. | 32 | 1 | 1 | 0 | €105.60 | €125.91 | 19.231% |
| Catalyst Pharmaceutical Partners Inc | 14 | 0 | 0 | 0 | €17.89 | €26.64 | 48.948% |
| Drägerwerk AG & Co. KGaA ST | 3 | 0 | 0 | 0 | €44.40 | €66.00 | 48.649% |
| EssilorLuxottica SA | 3 | 0 | 1 | 0 | €215.00 | €260.00 | 20.930% |
| Novo Nordisk A/S | 5 | 0 | 0 | 0 | €185.00 | €195.00 | 5.405% |